India extends price caps to 52 more essential drugs

An employee of Lupin Limited works at a reception at their headquarters in MumbaiBy Zeba Siddiqui MUMBAI (Reuters) – India has extended price caps to 52 drugs deemed essential by the government, as the country's drug price regulator enforces measures to improve the affordability of medicines. The additional drugs, including painkillers and antibiotics, join a list of nearly 400 essential treatments under price control in India, where a majority of people live on less than $2 a day and health insurance is scarce. Indian law allows the National Pharmaceutical Pricing Authority (NPPA) regulator to fix prices of drugs on a list of essential medicines. …

Go to Source